MIRM4:01 PMMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)mirumpharma.com
MIRM4:01 PMMirum Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Updatemirumpharma.com
MIRM4:01 PMMirum Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 5, 2026mirumpharma.com
MIRM4:01 PMMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)mirumpharma.com
MIRM4:01 PMMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)mirumpharma.com
MIRM8:05 AMMirum Pharmaceuticals and Incyte Announce Pivotal Late-Breaking Results for Zilurgisertib in Fibrodysplasia Ossificans Progressiva Accepted for Presentation at ENDO 2026mirumpharma.com
MIRM12:00 PMMirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026mirumpharma.com
MIRM8:05 AMMirum Pharmaceuticals to Present Data Showcasing Leadership in Rare Liver Diseases at the EASL International Liver Congress 2026mirumpharma.com